APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Canine Influenza Vaccine Industry Research Report 2026

20 December 2025124 pages

Choose your research edition.

Industry ResearchCanine Influenza Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Influenza Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Canine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Influenza Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Influenza Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Canine Influenza Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Canine Influenza Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Canine Influenza Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Canine Influenza Vaccine include Bharat Biotech, CNBG, CSL Limited, LIAONING CHENGDA, Merck Animal Health, GSK, Roche, Novartis and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Canine Influenza Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Canine Influenza Vaccine Market by Company

Bharat Biotech

CNBG

CSL Limited

LIAONING CHENGDA

Merck Animal Health

GSK

Roche

Novartis

Zoetis

Canine Influenza Vaccine Segment by Type

H3N2 Vaccine

H3N8 Vaccine

Canine Influenza Vaccine Segment by Application

Vaccination Clinic

Pet Hospital

Others

Canine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Canine Influenza Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Canine Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Canine Influenza Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Canine Influenza Vaccine Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Canine Influenza Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Canine Influenza Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Canine Influenza Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Canine Influenza Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Canine Influenza Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Canine Influenza Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Canine Influenza Vaccine, Product Type & Application Table 14. Global Canine Influenza Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Canine Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bharat Biotech Company Information Table 19. Bharat Biotech Business Overview Table 20. Bharat Biotech Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bharat Biotech Canine Influenza Vaccine Product Portfolio Table 22. Bharat Biotech Recent Developments Table 23. CNBG Company Information Table 24. CNBG Business Overview Table 25. CNBG Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. CNBG Canine Influenza Vaccine Product Portfolio Table 27. CNBG Recent Developments Table 28. CSL Limited Company Information Table 29. CSL Limited Business Overview Table 30. CSL Limited Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. CSL Limited Canine Influenza Vaccine Product Portfolio Table 32. CSL Limited Recent Developments Table 33. LIAONING CHENGDA Company Information Table 34. LIAONING CHENGDA Business Overview Table 35. LIAONING CHENGDA Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio Table 37. LIAONING CHENGDA Recent Developments Table 38. Merck Animal Health Company Information Table 39. Merck Animal Health Business Overview Table 40. Merck Animal Health Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck Animal Health Canine Influenza Vaccine Product Portfolio Table 42. Merck Animal Health Recent Developments Table 43. GSK Company Information Table 44. GSK Business Overview Table 45. GSK Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. GSK Canine Influenza Vaccine Product Portfolio Table 47. GSK Recent Developments Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Roche Canine Influenza Vaccine Product Portfolio Table 52. Roche Recent Developments Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Novartis Canine Influenza Vaccine Product Portfolio Table 57. Novartis Recent Developments Table 58. Zoetis Company Information Table 59. Zoetis Business Overview Table 60. Zoetis Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zoetis Canine Influenza Vaccine Product Portfolio Table 62. Zoetis Recent Developments Table 63. Global Canine Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Canine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 65. Global Canine Influenza Vaccine Sales Market Share by Region (2021-2026) Table 66. Global Canine Influenza Vaccine Sales by Region (2027-2032) & (W Units) Table 67. Global Canine Influenza Vaccine Sales Market Share by Region (2027-2032) Table 68. Global Canine Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Canine Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 70. Global Canine Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Canine Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 72. North America Canine Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 74. North America Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 75. North America Canine Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Canine Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Canine Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 79. Europe Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 80. Europe Canine Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Canine Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Canine Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 84. Asia Pacific Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 85. Asia Pacific Canine Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Canine Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Canine Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 89. South America Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 90. South America Canine Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Canine Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Canine Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 94. Middle East and Africa Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 95. Middle East and Africa Canine Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Canine Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 98. Global Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 99. Global Canine Influenza Vaccine Sales Market Share by Type (2021-2026) Table 100. Global Canine Influenza Vaccine Sales Market Share by Type (2027-2032) Table 101. Global Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 104. Global Canine Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 105. Global Canine Influenza Vaccine Price by Type (2021-2026) & (US$/Unit) Table 106. Global Canine Influenza Vaccine Price by Type (2027-2032) & (US$/Unit) Table 107. Global Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 108. Global Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 109. Global Canine Influenza Vaccine Sales Market Share by Application (2021-2026) Table 110. Global Canine Influenza Vaccine Sales Market Share by Application (2027-2032) Table 111. Global Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 114. Global Canine Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 115. Global Canine Influenza Vaccine Price by Application (2021-2026) & (US$/Unit) Table 116. Global Canine Influenza Vaccine Price by Application (2027-2032) & (US$/Unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Canine Influenza Vaccine Distributors List Table 120. Canine Influenza Vaccine Customers List Table 121. Canine Influenza Vaccine Industry Trends Table 122. Canine Influenza Vaccine Industry Drivers Table 123. Canine Influenza Vaccine Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Canine Influenza Vaccine Product Image Figure 5. Global Canine Influenza Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Canine Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Canine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 8. Global Canine Influenza Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. H3N2 Vaccine Product Image Figure 10. H3N8 Vaccine Product Image Figure 11. Vaccination Clinic Product Image Figure 12. Pet Hospital Product Image Figure 13. Others Product Image Figure 14. Global Canine Influenza Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Canine Influenza Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Canine Influenza Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Canine Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Canine Influenza Vaccine Sales by Region in 2025 Figure 20. Global Canine Influenza Vaccine Revenue by Region in 2025 Figure 21. North America Canine Influenza Vaccine Market Size by Country in 2025 Figure 22. North America Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America Canine Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Canine Influenza Vaccine Market Size by Country in 2025 Figure 27. Europe Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe Canine Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Canine Influenza Vaccine Market Size by Country in 2025 Figure 35. Asia Pacific Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Canine Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 37. China Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Canine Influenza Vaccine Market Size by Country in 2025 Figure 46. South America Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 47. South America Canine Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 48. Mexico Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Canine Influenza Vaccine Market Size by Country in 2025 Figure 52. Middle East and Africa Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Canine Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Turkey Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Canine Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Canine Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 58. Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 59. Global Canine Influenza Vaccine Price (US$/Unit) by Type (2021-2032) Figure 60. Global Canine Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 61. Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 62. Global Canine Influenza Vaccine Price (US$/Unit) by Application (2021-2032) Figure 63. Canine Influenza Vaccine Value Chain Figure 64. Canine Influenza Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Canine Influenza Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • H3N2 Vaccine
  • H3N8 Vaccine
Applications
  • Vaccination Clinic
  • Pet Hospital
  • Others
Companies covered
  • Bharat Biotech
  • CNBG
  • CSL Limited
  • LIAONING CHENGDA
  • Merck Animal Health
  • GSK
  • Roche
  • Novartis
  • Zoetis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Canine Influenza Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Canine Influenza Vaccine Sales (2021-2032)
  5. 2.2.3 Global Canine Influenza Vaccine Market Average Price (2021-2032)
  6. 2.3 Canine Influenza Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 H3N2 Vaccine
  9. 2.3.3 H3N8 Vaccine
  10. 2.4 Canine Influenza Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Vaccination Clinic
  13. 2.4.3 Pet Hospital
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Canine Influenza Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Canine Influenza Vaccine Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Canine Influenza Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Canine Influenza Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Canine Influenza Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Canine Influenza Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Canine Influenza Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Canine Influenza Vaccine, Established Date
  9. 3.9 Global Canine Influenza Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bharat Biotech
  2. 4.1.1 Bharat Biotech Company Information
  3. 4.1.2 Bharat Biotech Business Overview
  4. 4.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bharat Biotech Canine Influenza Vaccine Product Portfolio
  6. 4.1.5 Bharat Biotech Recent Developments
  7. 4.2 CNBG
  8. 4.2.1 CNBG Company Information
  9. 4.2.2 CNBG Business Overview
  10. 4.2.3 CNBG Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 CNBG Canine Influenza Vaccine Product Portfolio
  12. 4.2.5 CNBG Recent Developments
  13. 4.3 CSL Limited
  14. 4.3.1 CSL Limited Company Information
  15. 4.3.2 CSL Limited Business Overview
  16. 4.3.3 CSL Limited Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CSL Limited Canine Influenza Vaccine Product Portfolio
  18. 4.3.5 CSL Limited Recent Developments
  19. 4.4 LIAONING CHENGDA
  20. 4.4.1 LIAONING CHENGDA Company Information
  21. 4.4.2 LIAONING CHENGDA Business Overview
  22. 4.4.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio
  24. 4.4.5 LIAONING CHENGDA Recent Developments
  25. 4.5 Merck Animal Health
  26. 4.5.1 Merck Animal Health Company Information
  27. 4.5.2 Merck Animal Health Business Overview
  28. 4.5.3 Merck Animal Health Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck Animal Health Canine Influenza Vaccine Product Portfolio
  30. 4.5.5 Merck Animal Health Recent Developments
  31. 4.6 GSK
  32. 4.6.1 GSK Company Information
  33. 4.6.2 GSK Business Overview
  34. 4.6.3 GSK Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GSK Canine Influenza Vaccine Product Portfolio
  36. 4.6.5 GSK Recent Developments
  37. 4.7 Roche
  38. 4.7.1 Roche Company Information
  39. 4.7.2 Roche Business Overview
  40. 4.7.3 Roche Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Roche Canine Influenza Vaccine Product Portfolio
  42. 4.7.5 Roche Recent Developments
  43. 4.8 Novartis
  44. 4.8.1 Novartis Company Information
  45. 4.8.2 Novartis Business Overview
  46. 4.8.3 Novartis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Novartis Canine Influenza Vaccine Product Portfolio
  48. 4.8.5 Novartis Recent Developments
  49. 4.9 Zoetis
  50. 4.9.1 Zoetis Company Information
  51. 4.9.2 Zoetis Business Overview
  52. 4.9.3 Zoetis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zoetis Canine Influenza Vaccine Product Portfolio
  54. 4.9.5 Zoetis Recent Developments
5 Global Canine Influenza Vaccine Market Scenario by Region
  1. 5.1 Global Canine Influenza Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Canine Influenza Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Canine Influenza Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Canine Influenza Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Canine Influenza Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Canine Influenza Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Canine Influenza Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Canine Influenza Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Canine Influenza Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Canine Influenza Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Canine Influenza Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Canine Influenza Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Canine Influenza Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Canine Influenza Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Canine Influenza Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Canine Influenza Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Canine Influenza Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Canine Influenza Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Canine Influenza Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Canine Influenza Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Canine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Canine Influenza Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Canine Influenza Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Canine Influenza Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Canine Influenza Vaccine Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Canine Influenza Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Canine Influenza Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Canine Influenza Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Canine Influenza Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Canine Influenza Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Canine Influenza Vaccine Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Canine Influenza Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Canine Influenza Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Canine Influenza Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Canine Influenza Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Canine Influenza Vaccine Value Chain Analysis
  2. 8.1.1 Canine Influenza Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Canine Influenza Vaccine Production Mode & Process
  5. 8.2 Canine Influenza Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Canine Influenza Vaccine Distributors
  8. 8.2.3 Canine Influenza Vaccine Customers
9 Global Canine Influenza Vaccine Analyzing Market Dynamics
  1. 9.1 Canine Influenza Vaccine Industry Trends
  2. 9.2 Canine Influenza Vaccine Industry Drivers
  3. 9.3 Canine Influenza Vaccine Industry Opportunities and Challenges
  4. 9.4 Canine Influenza Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst